Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Sarah Kathryn Rouan currently holds 20,400 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sarah Kathryn Rouan has been a net seller of NAVB stock. They have purchased $4.9K and sold $1.4M worth of shares.
Sarah Kathryn Rouan's most recent insider trade was on Jan 2, 2026, when they sold 20,400 shares at $0.00 per share.
Sarah Kathryn Rouan serves as Executive at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB). They have executed 16 insider transactions totaling $1.4M over their tenure at the company.
Sarah Kathryn Rouan holds the position of Executive at NAVIDEA BIOPHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Sarah Kathryn Rouan has shown a selling trading pattern, with $4.9K in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Sarah Kathryn Rouan was on Feb 8, 2024, when they sold $701.3K worth of VKTX shares. This transaction involved 25,000 shares at $28.05 per share.
Sarah Kathryn Rouan currently owns 20,400 shares of NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Sarah Kathryn Rouan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Sarah Kathryn Rouan has 16 Form 4 filings on record as an insider at NAVIDEA BIOPHARMACEUTICALS, INC..
Set alerts for Sarah Kathryn Rouan and 40,000+ other insiders.